These insights collectively highlight the importance of early intervention strategies that target ICAM1 and its downstream NF‐κB signaling to alleviate local inflammation, protect BBB function, and promote brain tissue recovery following ICAS. The gene discussed is ICAM1; the disease is familial isolated congenital asplenia.